513 related articles for article (PubMed ID: 32246252)
1. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW
J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252
[TBL] [Abstract][Full Text] [Related]
2. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
3. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
4. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
6. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
7. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
Lang B; Makuch M; Moloney T; Dettmann I; Mindorf S; Probst C; Stoecker W; Buckley C; Newton CR; Leite MI; Maddison P; Komorowski L; Adcock J; Vincent A; Waters P; Irani SR
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):353-361. PubMed ID: 28115470
[TBL] [Abstract][Full Text] [Related]
8. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
[TBL] [Abstract][Full Text] [Related]
9. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
Michael S; Waters P; Irani SR
Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
[TBL] [Abstract][Full Text] [Related]
10. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
Yeo T; Chen Z; Chai JYH; Tan K
J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
[TBL] [Abstract][Full Text] [Related]
11. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings.
Baysal-Kirac L; Tuzun E; Erdag E; Ulusoy C; Vanli-Yavuz EN; Ekizoglu E; Peach S; Sezgin M; Bebek N; Gurses C; Gokyigit A; Vincent A; Baykan B
J Neurol; 2016 Mar; 263(3):455-66. PubMed ID: 26725084
[TBL] [Abstract][Full Text] [Related]
12. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
Front Immunol; 2021; 12():646940. PubMed ID: 33828556
[TBL] [Abstract][Full Text] [Related]
14. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
15. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
17. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
19. Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.
Prüss H; Lennox BR
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1242-1247. PubMed ID: 27435086
[TBL] [Abstract][Full Text] [Related]
20. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.
Klein CJ; Lennon VA; Aston PA; McKeon A; O'Toole O; Quek A; Pittock SJ
JAMA Neurol; 2013 Feb; 70(2):229-34. PubMed ID: 23407760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
